RFRP-3, the Mammalian Ortholog of GnIH, is a Novel Modulator Involved in Food Intake and Glucose Homeostasis.

Konglin Huo,Xun Li,Wen Hu,Xingxing Song,Duoni Zhang,Xin Zhang,Xinyi Chen,Jingzhi Yuan,Jianyu Zuo,Xiaoye Wang
DOI: https://doi.org/10.3389/fendo.2020.00194
IF: 6.055
2020-01-01
Frontiers in Endocrinology
Abstract:RF amide-related peptide 3 (RFRP-3) is a reproductive inhibitor and an endogenous orexigenic neuropeptide that may be involved in energy homeostasis. In this study, we evaluated the effect of acute or chronic RFRP-3 treatment (administered via intraperitoneal injection) on the food intake, meal microstructure and weight of rats, as well as the mechanism through which RFRP-3 is involved in glucose metabolism in the pancreas and glucose disposal tissues of rat in vivo. Our results showed that the intraperitoneal administration of RFRP-3 to rats resulted in marked body mass increased, hyperphagia, hyperlipidemia, hyperglycemia, glucose intolerance, hypoinsulinism, hyperglucagon, and insulin resistance, as well as significant increases in the size of pancreatic islets and the inflammatory reaction. Thus, we strongly assert that RFRP-3 as a novel neuroendocrine regulator involved in blood glucose homeostasis.
What problem does this paper attempt to address?